Trump: Hazardous to Our Health The Republicans now

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
567
Quote:
Trump: Hazardous to Our Health

Quote:
The Republicans now have a pre-existing condition: They voted for something that will cause them a lot of pain in the future.


Maureen Dowd MAY 6, 2017

07dowd-master768.jpg

President Trump sprinkling flimflam dust in the Rose Garden Thursday to deflect attention from the health care bill House Republicans had just passed. Credit Carlos Barria/Reuters

WASHINGTON — Will Donald Trump’s presidency get rotted out?
Steve Jobs might have said so.

Back in 1995, when the tech god was between gigs at Apple, when he had learned a thing or three about leadership by being snaked out of his own company by John Sculley, he gave an interview positing that empires could crash and burn if the emphasis was on sales rather than product.

“The companies forget what it means to make great products,” Jobs said. “The product sensibility and the product genius that brought them to that monopolistic position gets rotted out by people running these companies who have no conception of a good product versus a bad product. They have no conception of the craftsmanship that’s required to take a good idea and turn it into a good product. And they really have no feeling in their hearts usually about wanting to really help the customers.”

In “The Art of the Deal,” Trump said that playing to people’s fantasies and promising the greatest product was “an innocent form of exaggeration.”

But it’s one thing when you do that for condos and cologne and mattresses and steaks. It’s another for life-or-death health care policy.

Trump has twice pushed to pass disgraceful health care bills without even trying to grasp what’s in them — or more important, what’s not in them. He couldn’t care less that the dog’s breakfast served up by the House on Thursday wounds the struggling Americans he had promised to lift up.

It is “something terrific,” as he vowed, but only for the superrich who are getting a Marie Antoinette wealth transfer at the expense of health care for the poor.


The president feted his fake-news “win” in the Rose Garden, sprinkling flimflam dust to deflect from his ludicrous legislation. Paul Ryan slobbered over Trump’s leadership even as the Senate made plans to shred the House bill and start over.

“Hey, I’m president,” Trump told his sycophants, or in this case, sickophants. “Can you believe it, right?” No, I can’t.

In a moment of clueless cynicism, hours after the ego festival in the Rose Garden, Trump sat in a tuxedo with the Australian prime minister on the Intrepid and said Australians have better health care than Americans — harking back to his old statements in support of universal health care.

Presidents have to be good salesmen. Barack Obama faltered because he hated selling and simply lectured. He even outsourced the job of selling his re-election bid at the 2012 convention to a former antagonist, Bill Clinton.

Hillary was not good at salesmanship either. The new book “Shattered: Inside Hillary Clinton’s Doomed Campaign,” reports that at one point, her 2016 team got so flummoxed at her inability to explain why she wanted to be president that they actually considered the slogan “Because It’s Her Turn.”

Trump did care about his product when he built Trump Tower. He obsessed over every detail of a building that was the flashy emblem of New York bursting out of the dark ’70s and into the booming ’80s.
“But the success of that went to his head and he never cared again,” his biographer Tim O’Brien told me.


“He’s fundamentally lazy. He free-rides so many processes he doesn’t know anything about. He used to do it in the business world, and now he does it in the political world.

“He’s not a student of anything other than protecting his image. What he cares about is how he’s perceived, not the nuts and bolts of things. He is essentially a performance artist.”

When Trump talked to John Dickerson for “Face the Nation” last Sunday, he said the big difference between business and politics was that in Washington, “you really need heart, because you’re talking about a lot of people. Whereas in business, you don’t need so much heart. You want to make a good deal.”

But with health care, Trump wanted to make a deal so badly he was heartless. One Republican senator, Bill Cassidy of Louisiana, said that he would not vote for a health care bill that does not pass “the Jimmy Kimmel test”: “Would the child born with a congenital heart disease be able to get everything he or she would need in that first year of life?”

The House Republicans just wanted Trump off their backs. They had never pulled a real bill together because they thought Hillary would win and they could just snipe at her. The Irish undertaker and his crew were so desperate to prove they had not totally forgotten how to pass anything that they were willing to go with garbage.

And Ryan wanted to save the bacon — or bratwurst — of his fellow Wisconsin buddy Reince Priebus, blamed by Trump for the first health care defeat. After that debacle, The Times reported, Trump started merging the two names into one mocking “Ryan-ce.”

But in delivering this win for Trump, they may well have delivered a way for Democrats to take the president down. The Democrats could win the House back and get their investigative machinery cranking. The Cook Political Report has now downgraded the 2018 re-election chances of 20 House Republicans.

Trump cares only about optics, and yet he and Ivanka, his glossy shield on women’s issues, do not seem to realize the bad optics of a viral photo of a crowd of guys applauding themselves for gutting health care protections for women.

The Republicans now have a pre-existing condition: They voted for something that will cause them a lot of pain in the future.

Anne-Marie Hislop

Many of them simply wanted to go home and tell the folks that they voted to "repeal & replace" as they promised. They voted for their own bill saying that it would be greatly changed (presumably by the gown-ups on Capitol Hill - the Senate) before it came law.

In other words, folks, 'don't worry, the bill we passed is just a mock-up, not the real thing - but give me credit for passing a bill.'

Trump apparently doesn't even bother to read the bills for which he advocates or even the Executive Orders he signs. Maybe Priebus should send them over and have Fox News read them on TV so Trump will know what's in them.

stu freeman

The thing is The Donald used pretty much the same superlatives to describe the GOP's first health care bill as he did for the second. It's obvious that no one bothered to explain to him the rather huge differences between what was contained in the first bill (awful!) and what's included in the second (catastrophic!).

It's also obvious that he doesn't much care. What he wanted was a "victory" that would allow him to wipe out the legacy of his hated and popularly-elected predecessor.

The Marxist Muslim from Kenya needs to be eliminated from the pages of history, even if that requires eliminating the health insurance coverage of 24 million people- including many of those who actually voted for him.

And yet this not-ready-for-prime-time president has the audacity to maintain- as he did just yesterday- that Trumpcare II will insure all Americans at much lower premiums. A harmless exaggeration or a simple and sickening lie?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 22

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 20

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 23

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 13

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 20

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 17

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 18

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 17

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading

Top 5 Most Recently Viewed Articles

Taitron's Strategic Shift: Nasdaq Delisting and Financial Update

Updated Category News Views 251

Overview of Taitron's Recent Developments Taitron Components Incorporated (NASDAQ: TAIT) recently made headlines by announcing its voluntary delisting from The Nasdaq Stock Market. The company's decision came as it recognized that the cost of maintaining its Nasdaq listing outweighed the benefits for its shareholders. Reasons Behind the Delisting The board concluded that...

Continue Reading
Merck's Two-Drug HIV Treatment Achieves Trial Success

Updated Category News Views 130

Merck's Groundbreaking Two-Drug Regimen for HIV Treatment Recently, Merck & Co Inc (NYSE: MRK) announced promising results from two important Phase 3 clinical trials. This involved their investigational two-drug regimen combining doravirine and islatravir (DOR/ISL) aimed at treating adults living with HIV-1 infection. Key Findings from the Trials The trials were designed...

Continue Reading
Immunic’s Patent Milestone for Vidofludimus Calcium in MS

Updated Category News Views 230

Immunic Achieves Patent Allowance for Vidofludimus Calcium Immunic, Inc. (Nasdaq: IMUX), a leading biotechnology firm, has recently marked a significant milestone by receiving a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application focused on the use of vidofludimus calcium, particularly in the treatment of progressive...

Continue Reading
Creatd, Inc. Advances with OTCQB Approval and Strong Equity

Updated Category News Views 148

Creatd, Inc. Takes a Significant Step with OTCQB Approval Creatd, Inc. (OTC: CRTD) has reached a significant milestone by being approved to trade on the OTCQB Venture Market. This remarkable achievement showcases the company's dedication and progress towards enhancing its market presence. Starting from a pivotal date, Creatd will now be traded on a more recognized...

Continue Reading
KROMATID Unveils Groundbreaking KROMASURE PinPoint Technology

Updated Category News Views 155

KROMATID Launches KROMASURE PinPoint for Enhanced Genomic Analysis With an aim to transform gene therapy development, KROMATID has unveiled its innovative KROMASURE PinPoint system. This next-generation platform revolutionizes transgene integration analysis by providing single-cell resolution that was previously unattainable. Researchers now have the ability to detect...

Continue Reading